Solesence, Inc. (SLSN)
1.54
+0.03
(+1.99%)
USD |
NASDAQ |
Jan 12, 16:00
1.52
-0.02
(-1.30%)
After-Hours: 20:00
Solesence Research and Development Expense (Quarterly): 1.082M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| The Beauty Health Co. | 1.698M |
| Waldencast Plc | -- |
| European Wax Center, Inc. | -- |
| Grove Collaborative Holdings, Inc. | 1.626M |
| Kenvue, Inc. | 94.00M |